Zymework spurns All Blue Capital’s $773m takeover bid
Zymeworks' board of directors has rejected an unsolicited, non-binding acquisition offer from an affiliate of UK-based All Blue Capital.
Zymeworks' board of directors has rejected an unsolicited, non-binding acquisition offer from an affiliate of UK-based All Blue Capital.
Copyright PEI Media
Not for publication, email or dissemination